Anpralate Tablet 100 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.
MFDS item code 202007296 · Approved 2020.10.23
This product's status changed to Expired on 2025.10.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of ischemic symptoms related to chronic arterial occlusive disease (ulcers, pain, etc.)
This medication helps improve various symptoms associated with chronic arterial occlusive disease. For example, it alleviates ischemic symptoms such as ulcers, pain, and coldness caused by Buerger's disease, obstructive atherosclerosis, and diabetic peripheral vascular disease. Through this, it supports patients to have a more comfortable daily life. It improves blood circulation, promotes the recovery of damaged tissues, helps reduce pain, and enhances quality of life. Overall, it focuses on the improvement of ischemic symptoms to contribute to the health improvement of patients.
Sarpogrelate Hydrochloride: Take 100 mg orally three times a day after meals. Adjust dosage appropriately based on symptoms.
This medicine should not be used in patients with bleeding conditions as it may worsen bleeding, such as in hemophilia or gastrointestinal ulcers. Women who are pregnant or may become pregnant should avoid using this medicine due to reported harmful effects on the fetus in animal studies. Patients with genetic issues like lactose intolerance or galactose metabolism disorders should not take this medicine. It contains lactose which may worsen their symptoms. Women menstruating should use this medicine cautiously due to the risk of bleeding. Patients with bleeding tendencies or those taking medications that increase bleeding risk, such as anticoagulants or antiplatelet agents, should also take caution. Patients with severely impaired renal function should use this medicine judiciously as it may affect the excretion of the drug. Older adults may have decreased liver and kidney functions, which can increase drug concentrations; thus, starting at a lower dose and careful observation of their condition is advised. During treatment, patients should closely monitor for symptoms of bleeding, liver dysfunction, or blood abnormalities. Any issues should be reported to a healthcare provider immediately. Adverse effects such as skin rash, itching, vomiting, abdominal pain, palpitations, drowsiness may occur, and if such symptoms appear, the use of the medication should be discontinued and healthcare professionals consulted. Regular blood tests during treatment are recommended to ensure safe use by monitoring blood status and liver function. Inform healthcare professionals if used concurrently with anticoagulants or antiplatelet agents, as this can increase the risk of bleeding. Breastfeeding women should avoid using this medication as it may be excreted in breast milk; if it must be used, breastfeeding should be discontinued. The safety of this medicine in children has not been established, and therefore it is advisable not to use it in children. This medicine should be kept out of reach of children and should not be transferred to other containers to maintain its quality.
Gastrointestinal bleeding (hematemesis and melena, etc.), cerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, urticaria
Vomiting, stomatitis, nausea, foreign body sensation (in the esophagus), heartburn, abdominal pain, constipation, loss of appetite, abdominal bloating, diarrhea, palpitations, dyspnea, chest pain, facial flushing, hand swelling, drowsiness, taste disturbance, headache, dizziness, proteinuria, hematuria, elevated BUN, elevated creatinine, pharyngitis, pharyngeal discomfort, pharyngeal burning sensation, weight gain, elevated serum triglycerides, elevated serum cholesterol, decreased serum albumin, decreased serum calcium, glucosuria
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold areas.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.